Congress orders study of why Medicaid won't cover pregnancy monitoring devices
S. 141 — Connected MOM Act · Filed by Bill Cassidy (R-LA) · 4 cosponsors · Introduced Jan 16, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill directs the federal government to study why state Medicaid programs don't consistently cover remote health-monitoring devices (like pulse oximeters and blood pressure cuffs) for pregnant and postpartum women, and to recommend fixes. Within 18 months, HHS must report to Congress on barriers to coverage; within 6 months after that, HHS must update state guidance to align with those recommendations. No new money is appropriated; no mandate is imposed on states.
Why we flagged it
The bill is a directive for federal study and guidance-updating, not a direct appropriation or mandate. Its functional purpose is to identify and address coverage barriers for remote monitoring devices in state Medicaid programs serving pregnant and postpartum women.
What the text implies
- Device manufacturers (pulse oximeter, blood pressure cuff, glucose monitor makers) may benefit indirectly if HHS recommendations lead states to expand coverage, increasing demand and market size.
- The bill does not mandate state adoption of recommendations, so actual coverage expansion depends on state discretion and budget capacity — federal guidance alone may not overcome state fiscal constraints.
The full analysis lists 3 implications of this text.
Who stands to gain
remote monitoring device manufacturers (pulse oximeters, blood pressure monitors, scales, glucose mo; telehealth platforms and service providers (if coverage expansion includes remote monitoring service